These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 32069794
1. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge. Sankari H, Hietikko M, Kurppa K, Kaukinen K, Mansikka E, Huhtala H, Laurila K, Reunala T, Hervonen K, Salmi T, Lindfors K. Nutrients; 2020 Feb 13; 12(2):. PubMed ID: 32069794 [Abstract] [Full Text] [Related]
2. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Collin P, Salmi TT, Hervonen K, Kaukinen K, Reunala T. Ann Med; 2017 Feb 13; 49(1):23-31. PubMed ID: 27499257 [Abstract] [Full Text] [Related]
3. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet. Reunala T, Salmi TT, Hervonen K. Acta Derm Venereol; 2015 Nov 13; 95(8):917-22. PubMed ID: 26059085 [Abstract] [Full Text] [Related]
4. Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut. Hietikko M, Hervonen K, Ilus T, Salmi T, Huhtala H, Laurila K, Rauhavirta T, Reunala T, Kaukinen K, Lindfors K. Acta Derm Venereol; 2018 Mar 13; 98(3):366-372. PubMed ID: 29182792 [Abstract] [Full Text] [Related]
5. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease. Hietikko M, Koskinen O, Kurppa K, Laurila K, Saavalainen P, Salmi T, Ilus T, Huhtala H, Kaukinen K, Lindfors K. BMC Immunol; 2018 Dec 06; 19(1):36. PubMed ID: 30522434 [Abstract] [Full Text] [Related]
6. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis. Salmi TT, Hervonen K, Laurila K, Collin P, Mäki M, Koskinen O, Huhtala H, Kaukinen K, Reunala T. Acta Derm Venereol; 2014 Jul 06; 94(4):393-7. PubMed ID: 24352382 [Abstract] [Full Text] [Related]
7. Gluten T cell epitope targeting by TG3 and TG6; implications for dermatitis herpetiformis and gluten ataxia. Stamnaes J, Dorum S, Fleckenstein B, Aeschlimann D, Sollid LM. Amino Acids; 2010 Nov 06; 39(5):1183-91. PubMed ID: 20300788 [Abstract] [Full Text] [Related]
8. Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis. Salmi TT, Kurppa K, Hervonen K, Laurila K, Collin P, Huhtala H, Saavalainen P, Sievänen H, Reunala T, Kaukinen K. Dig Liver Dis; 2016 Jun 06; 48(6):632-7. PubMed ID: 27026081 [Abstract] [Full Text] [Related]
9. Dermatitis herpetiformis. Kárpáti S. Clin Dermatol; 2012 Jun 06; 30(1):56-9. PubMed ID: 22137227 [Abstract] [Full Text] [Related]
10. T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis. Caproni M, Capone M, Rossi MC, Santarlasci V, Maggi L, Mazzoni A, Rossettini B, Renzi D, Quintarelli L, Bianchi B, Ninci A, Lami G, Calabrò A, Cosmi L, Annunziato F, Liotta F. Front Immunol; 2021 Jun 06; 12():645143. PubMed ID: 33959126 [Abstract] [Full Text] [Related]
11. [Dermatitis herpetiformis]. Juratli HA, Görög A, Sárdy M. Hautarzt; 2019 Apr 06; 70(4):260-264. PubMed ID: 30868254 [Abstract] [Full Text] [Related]
12. Co-localization of IgA and TG3 on healthy skin of coeliac patients. Cannistraci C, Lesnoni La Parola I, Cardinali G, Bolasco G, Aspite N, Stigliano V, Picardo M. J Eur Acad Dermatol Venereol; 2007 Apr 06; 21(4):509-14. PubMed ID: 17373979 [Abstract] [Full Text] [Related]
13. Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease. Kaunisto H, Salmi T, Lindfors K, Kemppainen E. Int J Mol Sci; 2022 Mar 08; 23(6):. PubMed ID: 35328331 [Abstract] [Full Text] [Related]
14. TG6 Auto-Antibodies in Dermatitis Herpetiformis. Hadjivassiliou M, Reunala T, Hervonen K, Aeschlimann P, Aeschlimann D. Nutrients; 2020 Sep 21; 12(9):. PubMed ID: 32967363 [Abstract] [Full Text] [Related]
15. Dermatitis Herpetiformis: Novel Perspectives. Antiga E, Maglie R, Quintarelli L, Verdelli A, Bonciani D, Bonciolini V, Caproni M. Front Immunol; 2019 Sep 21; 10():1290. PubMed ID: 31244841 [Abstract] [Full Text] [Related]
16. Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, Taylor T, Jaskowski TD, Hill HR, Zone JJ. Br J Dermatol; 2008 Jul 21; 159(1):120-4. PubMed ID: 18503599 [Abstract] [Full Text] [Related]
17. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Salmi TT, Collin P, Korponay-Szabó IR, Laurila K, Partanen J, Huhtala H, Király R, Lorand L, Reunala T, Mäki M, Kaukinen K. Gut; 2006 Dec 21; 55(12):1746-53. PubMed ID: 16571636 [Abstract] [Full Text] [Related]
18. Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis. Kemppainen E, Salmi T, Lindfors K. Front Immunol; 2021 Dec 21; 12():657280. PubMed ID: 33854513 [Abstract] [Full Text] [Related]
19. Separate Gut Plasma Cell Populations Produce Auto-Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis. Das S, Stamnaes J, Kemppainen E, Hervonen K, Lundin KEA, Parmar N, Jahnsen FL, Jahnsen J, Lindfors K, Salmi T, Iversen R, Sollid LM. Adv Sci (Weinh); 2023 Sep 21; 10(25):e2300401. PubMed ID: 37424036 [Abstract] [Full Text] [Related]
20. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits. Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K. BMC Immunol; 2008 Feb 29; 9():6. PubMed ID: 18312620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]